Good MorningEquities rebounded on Wednesday but it is too soon to call a bottom in the market. While the S&P 500 is moving up from the key 4,200 level the move is ahead of an important data point that could change the market's outlook. That data point is the PCE price index on Friday. The PCE Price index is expected to moderate on a sequential basis but still come in at a strong up .03% for the month and 5.3% from last year.
The risk for the market is that inflation will not moderate and there is no real reason to think it will. Not only is energy at the highest levels in a decade and driving input costs higher throughout the economy but producers and retailers are still trying to catch up with the last 12 months of inflation. If anything, the market should be prepared for a hot number and a chance the S&P 500 could break through support at 4,200 and make a move toward the 2,700 level. Featured:
Our #1 Small-Cap Stock for April (BehindtheMarkets) 
|
Markets | | | Document management solutions and systems provider Xerox Holdings Corporation (NYSE: XRX) stock has fallen back towards pandemic lows with its surprising disappointment for Q1 fiscal 2022 earnings report. Read the Full Story |
|
|
Markets | | | With the major indices being slammed right down towards their lows of the year this week, there was a lot riding on Microsoft’s (NASDAQ: MSFT) earnings last night. The tech giant reported their fiscal Q3 numbers after the bell and they were, for the most part, viewed favorably by the street.&n... Read the Full Story |
|
Markets | | | Casino operator Las Vegas Sands (NYSE: LVS) stock has fallen toward its COVID-19 lows. The casino operator continues to see uncertainty grow in its Macao operations being affected by China’s zero-tolerance COVID policy. There is also fears of regulatory changes that further the crackdown on co... Read the Full Story |
|
From Our PartnersEach was hand-picked by a Zacks research expert as the #1 favorite stock to gain +100% or more in the months ahead. Previous editions of this Special Report have racked up huge gains, soaring as much as +359%, +498%, even +673%. | | Free today. |
|
Politics | | | KYIV, Ukraine -- Mariupol authorities are sounding the alarm about unsanitary conditions in the ravaged port city that they say pose a “deadly danger” to its remaining residents.
Mariupol City Council said on the messaging app Telegram Thursday that “deadly epidemics may break out in ... Read the Full Story |
|
Politics | | | KYIV, Ukraine — United Nations Secretary-General Antonio Guterres has toured areas outside the Ukrainian capital that suffered damage during the Russian advance there.
Speaking to journalists on Thursday at several points, Guterres urged Russia to cooperate with the International Crim... Read the Full Story |
|
From Our PartnersJeff Clark - "I Never Worry About Where The Market Is Headed. I Only Trade One Stock" | | | | Learn More |
|
Politics | | | BERLIN — German lawmakers have voted in favor of sending heavy weapons to Ukraine, a symbolic decision that reflects the government’s change of course on the issue.
Germany had initially refused to send any offensive weapons to Ukraine and later balked at sending heavy equipment such ... Read the Full Story |
|
Markets | | | As great as the risks to the economy are right now, the results from Automatic Data Processing (NYSE: ADP) prove the labor market and business, in general, are doing OK. The company not only reported a stronger than expected quarter but was also able to guide the coming quarter higher. Read the Full Story |
|
Markets | | | Better-than-expected sales of a COVID-19 treatment and its cancer blockbuster Keytruda helped push Merck past analyst profit forecasts in the first quarter.
The drugmaker said Thursday that its coronavirus capsule treatment Lagevrio brought in almost $3.2 billion in sales in the quar... Read the Full Story |
|
Politics | | | Ukraine said Thursday that Russia’s offensive in the east picked up momentum, with several towns coming under intense attack as Moscow's forces attempt to surround Ukrainian troops.
In a reminder of the horrific toll the war has taken since it began Feb. 24, United Nations Secretary-G... Read the Full Story |
|
Markets | | | Shares of Kraft Heinz (NASDAQ: KHC) wobbled in the wake of the Q1 earnings report despite better than expected results and an increase in the guidance. The results, as good as they are, are driven in large part by higher prices and only partially offset YOY declines attributable to tough comps and divestitures. Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is based in Chesterbrook, Pennsylvania. | | View Today's Stock Pick |
|
